Investigative ophthalmology & visual science۲۰۲۵۱ استنادنمایه شده در PubMed
Omer Trivizki, Charles C Wykoff, Magda A Smoor, David Rabinovitch, Avery Zhou, Jessica A Cao, Yara T E Lechanteur, Lambert van den Heuvel, Alain J van Gool, Jolein Gloerich, Joëlle E Vergroesen, Caroline C W Klaver
چکیده
Pegcetacoplan, a complement component 3 (C3) inhibitor, has recently received U.S. Food and Drug Administration approval for treating geographic atrophy (GA), an advanced stage of age-related macular degeneration (AMD). However, the limited treatment response prompts further investigations into its…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1167/iovs.66.15.24